Phosphatidylcholine is the major phospholipid providing arachidonic acid for prostacyclin synthesis in thrombin-stimulated human endothelial cells.

Abstract:

:Upon incubation for 24 hours with [3H]arachidonic acid (AA, 1 mu Ci/ml), cultured endothelial cells from human umbilical vein incorporated one half of the added radioactivity, mostly into phospholipids (83% of the total cell radioactivity). Distribution of the label between the various phospholipid classes was found to reflect the distribution of endogenous AA. Stimulation with human thrombin (2 U/ml) promoted a rapid release of radioactive material into supernatants, which contained essentially 6-keto-prostaglandin F1 alpha and non-converted AA. This process levelled off at 10 min, at which time phosphatidylcholine displayed a decrease accounting for 3.7% of the total cell radioactivity. Phosphatidylinositol also appeared significantly diminished, but this decrease was almost 2.5 fold less than that observed in phosphatidylcholine. It is concluded that AA availability for prostacyclin biosynthesis is mostly regulated by a phospholipase A2.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Thomas JM,Hullin F,Chap H,Douste-Blazy L

doi

10.1016/0049-3848(84)90068-9

subject

Has Abstract

pub_date

1984-04-15 00:00:00

pages

117-23

issue

2

eissn

0049-3848

issn

1879-2472

journal_volume

34

pub_type

杂志文章
  • A study on the properties of commercial thrombin preparations.

    abstract::Three commercial thrombin preparations used clinically to stop topical bleeding were studied. The specific activities of these preparations were 1,064 U/mg (human); 59 U/mg (bovine) and 147 U/mg (bovine). SDS-PAGE analysis of the human product produced one major band corresponding to a molecular weight of alpha-thromb...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90102-3

    authors: Suzuki S,Sakuragawa N

    更新日期:1989-02-01 00:00:00

  • Recombinant human protein C: comparative functional studies with human plasma protein C.

    abstract::Protein C (PC) is the central protein in a major antithrombotic regulatory mechanism. Hereditary deficiencies of PC are associated with thrombosis. Therapeutic PC replacement may be an important treatment if pure functional human protein C is available in sufficient quantity. Human PC has been produced on a commercial...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90258-e

    authors: Madden RM,Oppenheimer C,Wydro R,Marlar RA

    更新日期:1990-02-01 00:00:00

  • Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: a prospective study.

    abstract:BACKGROUND:Multiple sclerosis (MS) often causes progressive loss of mobility, leading to limb paralysis. Venous and lymphatic stasis is a risk condition for venous thromboembolism (VTE). There is, however, no data on the frequency of VTE complicating the progression of MS. The aim of this study was to assess the freque...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.06.023

    authors: Arpaia G,Bavera PM,Caputo D,Mendozzi L,Cavarretta R,Agus GB,Milani M,Ippolito E,Cimminiello C

    更新日期:2010-04-01 00:00:00

  • Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin.

    abstract::The present investigation has used an aggregation-disaggregation-reaggregation model to determine if exposure to potent aggregating agents causing a refractory state in deaggregated platelets results in down-regulation and clearance of GPIb/IX, the receptor for von willebrand factor. Thrombin, the thrombin receptor ac...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(96)00185-5

    authors: White JG,Rao GH

    更新日期:1996-11-15 00:00:00

  • Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets.

    abstract::Ajoene, the major antiplatelet compound derived from garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole. For collagen-induced platelet aggregation in human PRP, the ID50 for ajoene is 95 +/- 5 microM. However, in the presence of the antiaggregatory ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90259-8

    authors: Apitz-Castro R,Escalante J,Vargas R,Jain MK

    更新日期:1986-05-01 00:00:00

  • The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats.

    abstract:INTRODUCTION:Excessive platelet activation fundamentally contributes to cardiovascular events and mortality in patients with diabetes mellitus. Functional resistance has been described for current antiplatelet therapies in broad populations that include patients with diabetes. We investigated acute and chronic effects ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.09.025

    authors: Flierl U,Schöpp C,Jaitner J,Bauersachs J,Schäfer A

    更新日期:2010-03-01 00:00:00

  • Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives.

    abstract::Sandwich ELISA systems were developed to measure human von Willebrand factor (vWF). In one system the microtitre plates were coated with goat F(ab')2 to vWF. The F(ab')2 different molecular forms in the soluble phase. VWF antigen bound by the F(ab')2 antibody was subsequently determined by using horse-radish peroxidas...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90047-2

    authors: Silveira AM,Yamamoto T,Adamson L,Hessel B,Blombäck B

    更新日期:1986-07-01 00:00:00

  • The direct binding of human factor VII in plasma to recombinant human tissue factor.

    abstract::The extrinsic pathway of coagulation is initiated when zymogen factor VII binds to its cell surface receptor tissue factor. Recently recombinant human tissue factor has become available and therefore in this study the direct binding of human factor VII in plasma to recombinant tissue factor was explored. Factor VII bi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(93)90103-u

    authors: Sridhara S,Clarke BJ,Ofosu FA,High KA,Blajchman MA

    更新日期:1993-05-15 00:00:00

  • Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome.

    abstract:BACKGROUND:HELLP (Hemolysis, elevated liver enzymes and low platelets) syndrome is a severe and acute pregnancy-related disorder that occurs in approximately 2.5 per 1000 deliveries and represents a major cause of maternal and perinatal morbidity and mortality. This syndrome has been suggested to be a microangiopathy a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.08.038

    authors: Bazzan M,Todros T,Tedeschi S,Ardissino G,Cardaropoli S,Stella S,Montaruli B,Marchese C,Roccatello D,Cugno M

    更新日期:2020-12-01 00:00:00

  • Ionomycin, a Ca++ ionophore, increases platelet volume independently of the Na+/H+ exchanger.

    abstract::A Ca++-ionophore, ionomycin, increased the volume of human platelets suspended in a Ca++-containing buffer. This change in cell volume was dependent upon ionomycin and extracellular Ca++ concentrations, suggesting that the volume change occurs when the intracellular Ca++ reaches a certain level (greater than uM as det...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90197-k

    authors: Ozaki Y,Matsumoto Y,Yatomi Y,Higashihara M,Kariya T,Kume S

    更新日期:1990-01-01 00:00:00

  • Platelet and clotting activities after cold stress in diabetic patients.

    abstract::Platelet and clotting abnormalities have been described in diabetes, but little is known about their relationship to daily stresses. In order to evaluate whether states of abnormal carbohydrate metabolism modify the hemostatic response to stress, 12 subjects with type I diabetes mellitus, 9 with type II, 7 with impair...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(88)90348-9

    authors: Maiello M,Boeri D,Bonadonna R,Odetti P,Saccarello A,Adezati L

    更新日期:1988-06-15 00:00:00

  • Estimation of EDRF and nitric oxide release using [3H]GTP-labeled human platelets.

    abstract::We have developed a new bioassay for endothelium-derived relaxing factor (EDRF) or nitric oxide (NO) using human [3H]guanosine triphosphate (GTP)-labeled platelets. The labeled platelets were preincubated with isobutyl-methylxanthine and co-cultured with endothelial cells and the [3H]cyclic guanosine monophosphate (cG...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)00082-3

    authors: Kishi Y,Watanabe R,Ashikaga T,Numano F

    更新日期:1995-06-15 00:00:00

  • Current status of thrombolytics-the need for better, especially safer, agents.

    abstract::Clot dissolution using enzymes from the human fibrinolytic system has long been a goal of physicians and scientists. While recent focus has been on activators of the fibrinolytic system, new data support the use of plasmin itself. This supplement reviews the role of plasmin in fibrinolysis and locally administered pla...

    journal_title:Thrombosis research

    pub_type:

    doi:10.1016/j.thromres.2008.06.008

    authors: White GC 2nd

    更新日期:2008-01-01 00:00:00

  • A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of throm

    abstract:BACKGROUND:Rate of thalidomide-related VTE and risk factors in Japanese myeloma patients are not clear and effects of thromboprophylaxis remain controvertial. PATIENTS AND METHODS:We retrospectively analyzed a cohort data of registered Japanese myeloma patients treated with thalidomide-based regimens between 2009 and ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2012.11.014

    authors: Kato A,Takano H,Ichikawa A,Koshino M,Igarashi A,Hattori K,Nagata K

    更新日期:2013-02-01 00:00:00

  • Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.

    abstract::Major orthopaedic surgery is associated with an increased risk of venous thromboembolism. Direct oral anticoagulants (DOACs) are recommended as thromboprophylactic agents after orthopaedic surgery. Although routine monitoring of DOACs in general is not required, measuring DOAC concentration may be necessary in clinica...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.thromres.2016.01.012

    authors: Schellings MW,Boonen K,Schmitz EM,Jonkers F,van den Heuvel DJ,Besselaar A,Hendriks JG,van de Kerkhof D

    更新日期:2016-03-01 00:00:00

  • Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.

    abstract::Adenosine is an endogenous antiaggregating substance that influences the platelet responses through specific A-type receptors that activate adenylate cyclase increasing the levels of 3',5'-cyclic adenosine monophosphate (cAMP). In this study, we investigated whether adenosine can also influence the levels of 3',5'-cyc...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00412-1

    authors: Anfossi G,Russo I,Massucco P,Mattiello L,Cavalot F,Balbo A,Trovati M

    更新日期:2002-01-01 00:00:00

  • Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid.

    abstract::Eicosapentaenoic acid (EPA) has been reported to have a potent anti-aggregatory activity and to be efficiently metabolized by 12-lipoxygenase, not by cyclooxygenase in platelets. In vitro effect of 12-lipoxygenase metabolites of EPA on platelet function was studied and compared with those of arachidonic acid (AA). The...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90248-3

    authors: Takenaga M,Hirai A,Terano T,Tamura Y,Kitagawa H,Yoshida S

    更新日期:1986-02-01 00:00:00

  • Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.

    abstract:INTRODUCTION:Animal models of thrombosis and hemostasis are critical for target validation in pharmaceutical research. Guinea pig haemostatic mechanisms, such as the platelet thrombin receptor repertoire, resemble those of humans. Measuring the performance characteristics of marketed antithrombotic drugs in guinea pig ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.03.010

    authors: Bird JE,Giancarli MR,Allegretto N,Barbera F,Wong P,Schumacher WA,Ogletree ML,Seiffert D

    更新日期:2008-01-01 00:00:00

  • In vitro studies on the effect of activated protein C on platelet activation and thrombin generation.

    abstract::The effect of activated protein C (APC) on agonist-induced platelet activation and on thrombin generation after intrinsic (IA) and extrinsic (EA) activation of the coagulation system was studied by flow cytometry and by measuring levels of prothrombin fragment F1+2. In platelet activation studies blood drawn from heal...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(97)00119-9

    authors: Kaiser B,Jeske W,Hoppensteadt DH,Walenga JM,Drohan W,Fareed J

    更新日期:1997-07-15 00:00:00

  • Expression of PAI-1, t-PA and u-PA in cultured human umbilical vein endothelial cells derived from racial groups.

    abstract::To determine whether inherent fibrinolytic differences may exist in racial groups (black americans, BA vs. white americans, WA), 55 different individual racially-derived human umbilical vein endothelial cell (HUVEC) cultures (35 BA and 20 WA) were analyzed in terms of their fibrinolytic protein (t-PA, u-PA and PAI-1) ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)91615-r

    authors: Frist ST,Taylor HA Jr,Kirk KA,Grammer JR,Li XN,Grenett HE,Booyse FM

    更新日期:1995-02-01 00:00:00

  • Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.

    abstract:INTRODUCTION:Unfractionated heparin (UFH) does not cross the placenta and has demonstrated utility in the prevention and treatment of thrombosis during pregnancy. Limited information is available to guide initiation and monitoring of therapeutic UFH targeting an anti-Xa concentration of 0.3-0.7 u/ml during pregnancy. T...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.07.014

    authors: Clark NP,Delate T,Cleary SJ,Witt DM

    更新日期:2010-05-01 00:00:00

  • Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.

    abstract:BACKGROUND:Many heparin-induced thrombocytopenia (HIT) antibodies cause platelet activation in the serotonin release assay (SRA) in the absence of heparin. This in vitro observation may help unravel the mechanism of delayed-onset HIT, where seropositive patients develop thrombocytopenia and associated thrombosis after ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2009.10.021

    authors: Prechel MM,Jeske WP,Walenga JM

    更新日期:2010-04-01 00:00:00

  • Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia.

    abstract:INTRODUCTION:Thrombomodulin (TM) has been described as a marker of endothelial injury in atherosclerosis. The role of TM as a predictor of PAD severity is to be proven. The goal of the present study is to compare the level of plasmatic (TMp) in patients with intermittent claudication with patients with critical ischemi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.03.010

    authors: Nasser M,Wolosker N,Uint L,Rosoky RA,Lobato M,Wajngarten M,Puech-Leao P

    更新日期:2006-01-01 00:00:00

  • Antiphospholipid antibodies in children without and in adults with and without thrombophilia.

    abstract::Antiphospholipid antibodies (APAs) are considered risk factors in patients with thromboembolic diseases. Although the incidence of such acquired coagulation disturbances in adults are well described, only few data exist for children. Therefore, in a first step to collect new data we analyzed the presence of different ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00241-8

    authors: Siemens HJ,Gutsche S,Brückner S,Bucsky P,Katus HA

    更新日期:2000-05-15 00:00:00

  • Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.

    abstract:INTRODUCTION:In the prospective, randomised, double-blind, placebo-controlled Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL)-2 trial patients with acute myocardial infarction (AMI) and successful mechanical reperfusion received granulocyte-colony stimulating factor (G-CSF, 10 μg/...

    journal_title:Thrombosis research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.thromres.2010.11.004

    authors: Steppich BA,Demetz G,Schulz S,von Wedel J,Pogatsa-Murray G,Braun SL,Stein A,Kastrati A,Schömig A,Ott I

    更新日期:2011-02-01 00:00:00

  • A novel approach to thrombin inhibition.

    abstract::The inability of the heparin-antithrombin complex to inhibit fibrin-bound thrombin limits the utility of heparin for treatment of arterial thrombosis. In contrast with heparin, melagatran, a direct thrombin inhibitor (DTI), is equally effective at inhibiting fluid-phase thrombin and thrombin bound to fibrin. This refl...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/s0049-3848(03)00251-2

    authors: Weitz JI

    更新日期:2003-07-15 00:00:00

  • Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.

    abstract:BACKGROUND AND OBJECTIVE:According to US Food and Drugs Administration (FDA), 2 hour recombinant tissue plasminogen activator (rt-PA) 100mg infusion is recommended for eligible patients with acute pulmonary embolism (PE). However,there exists evidence implying that a lower dosage of rt-PA can be equally effective but p...

    journal_title:Thrombosis research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.thromres.2013.12.026

    authors: Zhang Z,Zhai ZG,Liang LR,Liu FF,Yang YH,Wang C

    更新日期:2014-03-01 00:00:00

  • Warfarin-induced factor VII deficiency and the bleeding time.

    abstract::The effect of warfarin-induced factor VII deficiency on the skin bleeding time was investigated in 10 consecutive patients with mean prothrombin times of 33 sec and factor VII levels of 7%. Bleeding times in all but one subject were entirely within the normal range. We conclude that warfarin administration, even to th...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90243-8

    authors: Green D,Ts'ao CH

    更新日期:1983-02-15 00:00:00

  • Proteomics reveals region-specific hemostatic alterations in response to mechanical ventilation in a preterm lamb model of lung injury.

    abstract:INTRODUCTION:Preterm infants often require assisted ventilation, however ventilation when applied to the immature lung can initiate ventilator-induced lung injury (VILI). The biotrauma which underscores VILI is largely undefined, and is likely to involve vascular injury responses, including hemostasis. We aimed to use ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.09.036

    authors: Schmid C,Ignjatovic V,Pang B,Nie S,Williamson NA,Tingay DG,Pereira-Fantini PM

    更新日期:2020-12-01 00:00:00

  • The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.

    abstract:INTRODUCTION:Uremic bleeding frequently occurs in dialysis patients. Although its mechanism is not well characterized, acquired platelet dysfunction has been implicated in its pathogenesis. Skin bleeding time has been used to characterize platelet dysfunction in this population. However, the bleeding time is prone to e...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2006.02.013

    authors: Brophy DF,Martin EJ,Carr SL,Kirschbaum B,Carr ME Jr

    更新日期:2007-01-01 00:00:00